Jim Ronca of Pennsylvania personal injury law firm Anapol Weiss recently won a $19.9 million settlement for patients affected by Bayer AG’s pharmaceutical drug, Trasylol. Mr. Ronca settled 20 cases in the national multi-district litigation and 19 cases in Pennsylvania.
The blood-preserving drug, which was approved for use during high risk heart bypass surgery and coronary bypass redo procedures, and later approved for all coronary bypass procedures, was alleged to cause kidney failure in some patients and increase the risk of death. Trasylol was available in the U.S. from 1993 until 2007 when the FDA requested that the drug be pulled off the market. In April 2008, the pharmaceutical giant recalled all stocks of Trasylol.
2006 saw the first Trasylol lawsuit filed by Anapol Weiss and the firm was one of the first to earn settlements in litigation. The firm believes that its case played a key role in settlement discussions for both its cases and 34 other cases pertaining to Trasylol.
Anapol Weiss was founded in 1977 and has established itself as a leading Pennsylvania civil justice and personal injury law firm. With success in handling a plethora of varying cases ranging from medical malpractice, truck accident injury, defective product, and dangerous drug litigation to unsafe toys, car crashes and other practice areas, the firm prides itself in providing injured individuals with the best legal representation possible. If you have been injured due to someone else’s negligence, contact the Philadelphia personal injury attorneys at Anapol Weiss by calling (866) 735-2792.